Actively Recruiting
The International SubcutaneouS Implantable Cardioverter Defibrillator Registry (iSuSI)
Led by University of Luebeck · Updated on 2024-07-01
4000
Participants Needed
1
Research Sites
169 weeks
Total Duration
On this page
Sponsors
U
University of Luebeck
Lead Sponsor
P
Prof. Jürgen Kuschyk, M.D
Collaborating Sponsor
AI-Summary
What this Trial Is About
The entirely subcutaneous implantable defibrillator (S-ICD) (Emblem, Boston Scientific, Marlborough, MA, USA) was introduced as a new therapeutic alternative to the conventional transvenous ICD in 2009 and implantations are rapidly expanding since then.1 Implantation of the S-ICD seems to reduce implant-related perioperative complications such as pneumothorax, hematoma and cardiac tamponade. The aim of this multicenter registry is thus to assess the outcome of patients following an S-ICD implantation in a real-world setting.
CONDITIONS
Official Title
The International SubcutaneouS Implantable Cardioverter Defibrillator Registry (iSuSI)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Implantation of an S-ICD, regardless of the technique
- At least 1 month of follow up
- At least 1 post-implantation assessment, in accordance to the routine clinical practice of every center (e.g. in person visit or remote follow up)
You will not qualify if you...
- none
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinic for Rhythmology
Lübeck, Schleswig-Holstein, Germany, 23538
Actively Recruiting
Research Team
J
Julia Vogler, Dr.
CONTACT
C
Cornelia Wolf
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here